📊 Note: Daily ratings and analytics are updated after market close and will be available by 7:00 PM IST.

Details

NameSymbolSector
COHANCE LIFESCIENCES LIMITEDCOHANCEPharmaceuticals
Open
308.95
High
317.5
Low
304
Close
311.95
Volume
497644
Exchange
nse
Time
01-Apr-2026

Outlook

Score:  

5.5

Rating:  

FAIR

Candlestick Pattern

Candle pattern of Cohance Lifesciences is  
Spinning Top
Estimated Stoploss of Cohance Lifesciences is ₹  
304
Cohance Lifesciences has a  
Bullishℹ
 pattern. 
Formation of  
Spinning Top
 candle pattern indicates the trend direction of Cohance Lifesciences is  
Unpredictableℹ
. 

Trend

Cohance Lifesciences is in  
Sideways trendℹ
. 
Price of Cohance Lifesciences is  
Downℹ
 by  

2.68

%. 
Target
Buy @ 

216.6

Sell @ 

495.48

Current @ 

311.95

Volume

The trade volumes of Cohance Lifesciences have become  
Deficientℹ
The volume trend for Cohance Lifesciences is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Cohance Lifesciences is  

Down

 by  

53.22

% 

Valuation

The current market price of Cohance Lifesciences is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 3031cr and total assets worth ₹ 3031cr, the balance sheet of Cohance Lifesciences is:  
Balancedℹ
. 
Cashflow
Cohance Lifesciences has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 38cr

. It is  
Upℹ
 by  

323.53

%. 

(*Mar 2025)

52.65% i.e. ₹ 288cr earned in operatingℹ
46.62% i.e. ₹ 255cr spent in investingℹ
0.55% i.e. ₹ 3cr earned in financingℹ
0.18% i.e. ₹ 1cr earned in otherℹ
Cohance Lifesciences has  
Poorℹ
 cash flow because there is  

Shortage

 of  

₹ 17cr

. It is  
Downℹ
 by  

185

%. 

(*Mar 2024)

48.84% i.e. ₹ 358cr earned in operatingℹ
49.39% i.e. ₹ 362cr spent in investingℹ
1.77% i.e. ₹ 13cr spent in financingℹ
0% in otherℹ
Income
The income of Cohance Lifesciences is  

₹ 571cr

 and  

Profit

 is :  

₹ 66cr

(*Sep 2025)

Cohance Lifesciences Profit is up by:  

21.05

% and Income is Up by:  

36.65

% 

(*Sep 2025)

The income of Cohance Lifesciences is  

₹ 563cr

 and  

Profit

 is :  

₹ 46cr

(*Jun 2025)

Cohance Lifesciences Profit is down by:  

54.22

% and Income is Up by:  

27.95

% 

(*Jun 2025)

The income of Cohance Lifesciences is  

₹ 412cr

 and  

Profit

 is :  

₹ 38cr

(*Mar 2025)

Cohance Lifesciences Profit is up by:  

2.47

% and Income is Up by:  

18.82

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.